SCHEMBL8960660

SCHEMBL8960660

c1ccc(-c2nc(-c3ccc[nH]3)sc2-c2ccccc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.49
ALDH1A1 P00352 3/20 0.49
CYP2D6 P10635 2/20 0.49
CYP2C19 P33261 2/20 0.49
MAPT P10636 2/20 0.49
KDM4E B2RXH2 1/20 0.44
CYP3A4 P08684 1/20 0.44
GAA P10253 1/20 0.44
CYP2C9 P11712 1/20 0.44
PTGS2 P35354 5/20 0.43
CDC7 O00311 3/20 0.41
DBF4 Q9UBU7 3/20 0.41
PTGS1 P23219 2/20 0.40
CYP1A1 P04798 3/20 0.40
CYP1B1 Q16678 3/20 0.40
MEN1 O00255 1/20 0.38
PKM P14618 1/20 0.38
MAPK1 P28482 1/20 0.38
HTT P42858 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8960651 0.87 CDC7 (0.47) CYP1A2ALDH1A1CYP2D6CYP2C19MAPT
SCHEMBL7852125 0.84 ALDH1A1 (0.50) ALDH1A1MAPTKDM4EGAAPTGS2
SCHEMBL9768642 0.79 ALDH1A1 (0.62) CYP1A2ALDH1A1CYP2D6CYP2C19MAPT
Hydrochloric Acid SCHEMBL30774640 0.75 ALDH1A1 (0.63) CYP1A2ALDH1A1CYP2D6CYP2C19MAPT
SCHEMBL7958280 0.74 IDO1 (0.57) ALDH1A1MAPTSMN1; SMN2
SCHEMBL21670773 0.71 PTGS2 (0.56) CYP1A2ALDH1A1CYP2D6CYP2C19MAPT
SCHEMBL11456658 0.71 CDC7 (0.67) CYP1A2ALDH1A1CYP2D6CYP2C19MAPT
SCHEMBL25028196 0.71 BCHE (0.36)
SCHEMBL9958269 0.70 ALDH1A1 (0.51) CYP1A2ALDH1A1CYP2D6CYP2C19MAPT
SCHEMBL12245630 0.70 ALOX5 (0.69) CYP1A2ALDH1A1CYP2D6CYP2C19MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0560136-B1 Neuroprotective drug KANEBO LTD (JP) 1996-01-24 EP disclosed
US-5399571-A Antihypoxic agents, brain disorders KANEBO, LTD. (JP) 1995-03-21 US disclosed
EP-0560136-A1 Neuroprotective drug KANEBO, LTD. (JP) 1993-09-15 EP disclosed